Technical Analysis for HVO - Hvivo Plc

Grade Last Price % Change Price Change
C 29.50 2.08% 0.60
HVO closed up 2.08 percent on Thursday, March 28, 2024, on 16 percent of normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
Gapped Up Strength 0.00%
Shooting Star Candlestick Bearish 2.08%
Doji - Bearish? Reversal 2.08%
Gapped Down Weakness 2.08%
Down 3 Days in a Row Weakness 3.51%
Down 4 Days in a Row Weakness 3.51%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.61%
Down 3 Days in a Row Weakness 2.61%
New Uptrend Bullish 1.37%
Inside Day Range Contraction 0.34%

   Recent Intraday Alerts

Alert Time
Down 1% 1 day ago
Gap Up Closed 1 day ago
Gap Up Partially Closed 1 day ago
Up 2% 1 day ago
10 DMA Support 1 day ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Hvivo Plc Description

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model. In addition, the company is developing a database of infectious disease progression data that include Disease in Motion platform, which comprises unique datasets, such as clinical, immunological, virological, and digital (wearable) biomarkers. The Disease in Motion platform has various potential applications across a range of end users, including big technology, wearables, pharma, and biotech companies. Further, the company provides pre­clinical and early clinical research services; sales and marketing services; and biometry, data management, and statistics to its various European pharmaceutical clients, as well as drug development consultancy and services, including CMC (chemistry, manufacturing, and controls), and PK and medical writing to a range of European clients. The company was formerly known as Open Orphan Plc and changed its name to hVIVO plc in October 2022. hVIVO plc is headquartered in London, the United Kingdom.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Manufacturing Disease Data Management Drug Development Infectious Disease Biomarker Asthma Malaria Cell Biology Copd

Is HVO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 32.0
52 Week Low 12.4966
Average Volume 4,025,352
200-Day Moving Average 21.32
50-Day Moving Average 27.78
20-Day Moving Average 27.97
10-Day Moving Average 29.00
Average True Range 1.26
RSI (14) 60.32
ADX 30.31
+DI 27.40
-DI 10.82
Chandelier Exit (Long, 3 ATRs) 28.22
Chandelier Exit (Short, 3 ATRs) 28.28
Upper Bollinger Bands 30.60
Lower Bollinger Band 25.33
Percent B (%b) 0.79
BandWidth 18.83
MACD Line 0.59
MACD Signal Line 0.48
MACD Histogram 0.1109
Fundamentals Value
Market Cap 200.71 Million
Num Shares 680 Million
EPS 0.00
Price-to-Earnings (P/E) Ratio 0.00
Price-to-Sales 3.34
Price-to-Book 9.19
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 31.00
Resistance 3 (R3) 30.83 30.17 30.75
Resistance 2 (R2) 30.17 29.78 30.25 30.67
Resistance 1 (R1) 29.83 29.55 30.00 30.00 30.58
Pivot Point 29.17 29.17 29.25 29.25 29.17
Support 1 (S1) 28.83 28.78 29.00 29.00 28.42
Support 2 (S2) 28.17 28.55 28.25 28.33
Support 3 (S3) 27.83 28.17 28.25
Support 4 (S4) 28.00